Publiziert in: Marktpuls, Unternehmen
Frei

Reminder: Invitation to Roche’s First Quarter Sales 2020 Audio Webcast and Conference Call Mittwoch, 15. April 2020 - 10:08

?v=05292019124700841935.png

Reminder: Invitation to Roche's First Quarter Sales 2020 Audio Webcast and Conference Call
 

 

rdpred-our-structure-placeholder-1920x750

Roche will publish its Sales Results for the 1st Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Wednesday, April 22nd, 2020

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)

Release will be e-mailed and posted on the Roche IR website > click here.
Presentation slides will be posted on the Roche IR website > 
click here

We would like to invite all interested parties to dial in as outlined below:

14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT

Audio webcast and conference call
 will start with presentations by senior management followed by a Q&A session (live access to the speakers).

Presenters:

  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer

To expedite the registration process on the day of the conference call, you may pre-register for the event > click here

Alternatively you may dial in to the conference 10-15 min prior to the scheduled start using the following numbers:
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)
Other international numbers are available 
here


Best regards,


Karl Mahler
Head of Investor Relations and Roche Group Planning


Roche Investor Relations

 

Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: 
karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: 
jon_kaspar.bayard@roche.com

Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: 
sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: 
bruno.eschli@roche.com

Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: 
birgit.masjost@roche.com

Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: 
gerard.tobin@roche.com

 

 

Investor Relations North America

 

Loren Kalm
Phone: +1 650 225 3217
e-mail: 
kalm.loren@gene.com

Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: 
tuomi.lisa@gene.com

 

 

Attachment

All rights reserved ©2020 F. Hoffmann-La Roche Ltd.
Investor Relations, Grenzacherstrasse 124, CH-4070 Basel, Switzerland